Sales Rep Overtime Issue Remains Unresolved As Supreme Court Declines To Review Novartis, Merck Rulings
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite a split in circuit courts as to whether sales reps are exempt from overtime pay, the Supreme Court denied certiorari petitions; companies may have to change their overtime compensation systems.
You may also be interested in...
GSK Sales Reps Are Latest To Urge Supreme Court To Review Overtime Pay
The court is being asked for the second time to address whether pharmaceutical sales reps are exempt from receiving overtime pay under the Fair Labor Standards Act.
GSK Sales Reps Are Latest To Urge Supreme Court To Review Overtime Pay
The court is being asked for the second time to address whether pharmaceutical sales reps are exempt from receiving overtime pay under the Fair Labor Standards Act.
Sales Rep Overtime Might Get Supreme Court Review; "Staggering Retroactive Liability" Is Worry
The court will consider certiorari petitions from Novartis and Schering at its Feb. 18 conference. An amicus brief from PhRMA paints a dire picture.